Theraclion

Equities

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 14:28:19 17/07/2024 BST			5-day change	1st Jan Change
0.316 ^EUR	-4.53%		-3.66%	-18.56%

06-24	Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	CI
06-07	Theraclion: scientific publication hailed by stock market	CF

Theraclion Announces Revenue Results for the Full Year of 2014

January 29, 2015 at 07:00 am

Theraclion announced revenue results for the full year of 2014. For the period, the company's sales of EUR 800,000 against EUR 15,000 a year ago. 97% of 2014 revenues were comprised of sales to three major customers: the American Hospital of Paris.

Latest news about Theraclion

Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	06-24	CI
Theraclion: scientific publication hailed by stock market	06-07	CF
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	24/10/23	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	11/10/23	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	27/09/23	CI
Theraclion: capital increase completed	23/06/23	CF
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	21/06/23	CI
Theraclion Names CEO	26/05/23	MT
Theraclion Appoints Martin Deterre as CEO	25/05/23	CI
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	24/05/23	CI
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23/05/23	CI
Global markets live: HSBC, Logitech, Uber, IBM, BP...	02/05/23
Theraclion SA Auditor Raises 'Going Concern' Doubt	28/04/23	CI
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Theraclion: FDA approves pivotal study with Sonovein	18/04/23	CF
France's Theraclion Gets US FDA Nod for Clinical Trial of Varicose Veins Treatment	18/04/23	MT
Theraclion SA Announces US Food Drug Administration Approve Investigational Device Exemption Application to Initiate the Multi-Center Pivotal Study VEINRESET for the Treatment of Primary Insufficiency of Great Saphenous Veins with SONOVEIN	17/04/23	CI
Theraclion: boosted by positive results from US study	31/01/23	CF
Theraclion Announces Results of First US Trial	30/01/23	CI
Theraclion: partnership with the University of Virginia	22/12/22	CF
University of Virginia Cancer Center to Use Theraclion's HD Technology	21/12/22	CI
Theraclion SA Announces Last Patient of First Sonovein(R) US Study Has Been Treated	17/10/22	CI
Theraclion New Echotherapy for Varicose Veins Partnership with Parisian Region Hospital Wound Center Announced	29/09/22	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2022	26/09/22	CI

Chart Theraclion

Duration

Period

More charts

Company Profile

Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of equipment (66.1%); - sale of consumables (27.8%); - provision of after-sales services (6.1%). Export accounts for 96.6% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

18/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERACLION	-18.56%	16.45M
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	187B
INTUITIVE SURGICAL, INC.	+26.34%	155B
BOSTON SCIENTIFIC CORPORATION	+33.90%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
AGILENT TECHNOLOGIES, INC.	-3.98%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.72B

Other Advanced Medical Equipment & Technology